Le Lézard
Classified in: Science and technology, Business
Subject: PER

Dataminr Announces the Departure of Nella Domenici, CFO


NEW YORK, Sept. 17, 2021 /PRNewswire/ -- Dataminr today announced that Nella Domenici will step down from her position as Chief Financial Officer (CFO) for health reasons, effective immediately.

"Nella has had an enormous impact helping accelerate the growth of our business, set our strategic direction and build and empower a high-performing and diverse team," said Ted Bailey, founder and CEO of Dataminr. "We're a stronger company because of her leadership and I'm grateful for all of her contributions to our ongoing success."

As CFO, Domenici held overall leadership and responsibility for finance, legal, and real estate. She participated in Dataminr's most important growth initiatives and critical transactions, including a series F Raise of $475 million at a $4.1 billion valuation and the execution of Dataminr's first acquisition, WatchKeeper, building a strong foundation for future growth. She also recruited and managed an extraordinarily diverse and talented team, with some of the highest professional satisfaction levels within the company. Domenici has agreed to provide consulting services to Dataminr.

"I'm deeply proud of my team's accomplishments and highly confident that they will continue to help drive the company's success," said Ms. Domenici. "This was a wonderful opportunity to have a transformational impact and I am deeply gratified in what we achieved together for Dataminr, its stakeholders, investors and customers."

About Dataminr

Dataminr delivers the earliest warnings on high impact events and critical information far in advance of other sources. Recognized as one of the world's leading AI businesses, Dataminr enables faster response, more effective risk mitigation, and stronger crisis management for public and private sector organizations spanning global corporations, first responders, NGOs, and newsrooms. Recently valued at $4.1B, Dataminr is one of New York's top private technology companies, with 750 employees across seven global offices.

Since its founding in 2009, Dataminr has created the world's leading real-time information discovery platform which detects digital patterns of emerging events and critical information from public data signals. Today, Dataminr's leading AI Platform performs trillions of daily computations across billions of public data inputs from over 180,000 unique public data sources. The company has been recognized for its groundbreaking AI Platform and rapid revenue growth by Forbes Cloud 100 and Deloitte Fast 500. Alongside Dataminr's corporate product, Dataminr Pulse, the company provides public sector organizations with First Alert for first response, including the United Nations which relies on First Alert in over 100 countries. Dataminr for News is used by more than 650 newsrooms and by over 30,000 journalists world-wide.

SOURCE Dataminr


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: